A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence.
Early breast cancer
To be considered for this study you must meet the following criteria:
- 50 years of age or older
- Have histologically confirmed breast cancer
This is a randomised study and your participation in this study would be approximately 5 years.
Patients randomized to Arm A will receive standard radiation therapy and adjuvant endocrine therapy (standard of care).
Patients randomized to Arm B will not receive radiation therapy (omission of radiation therapy) and receive adjuvant endocrine therapy only.
You will be required to attend clinic visit approximately every 6 months and be required to complete Quality of life questionnaires throughout the study.
For further information regarding this clinical trial click here.